Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.
Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.
复制标题
精神分裂症和双相情感障碍的神经代谢物 - 系统评价和荟萃分析。
DOI:
10.1016/j.pscychresns.2012.02.003
复制
发表时间:
2012-08
影响因子:
11.3
通讯作者:
Lahti AC
中科院分区:
文献类型:
--
作者:
Kraguljac NV;Reid M;White D;Jones R;den Hollander J;Lowman D;Lahti AC
This meta-analysis evaluates alterations of neurometabolites in schizophrenia and bipolar disorder. PubMed was searched to find controlled studies evaluating N-acetylaspartate (NAA), Choline (Cho) and Creatine (Cr) assessed with 1H-MRS (proton magnetic resonance spectroscopy) in patients with schizophrenia and bipolar disorder up to September 2010. Random effects meta-analyses were conducted to estimate pooled standardized mean differences. I2 statistic was used to quantify inconsistencies. Subgroup analyses were conducted to explore potential explanations for inconsistencies. 146 studies with 5643 participants were included in the systematic review. NAA levels were affected in schizophrenia and bipolar disorder. Decreased levels in the basal ganglia and frontal lobe were the most consistent findings in schizophrenia, decreased levels in the basal ganglia were the most consistent findings in bipolar disorder. Cho and Cr levels were not altered in either disorder. Findings for Cr were most consistent in the thalamus, frontal lobe and dorsolateral prefrontal cortex in schizophrenia and the basal ganglia and frontal lobe in bipolar disorder. Findings for Cho were most consistent in the thalamus, frontal lobe and anterior cingulate cortex in schizophrenia and basal ganglia in bipolar disorder. Large, carefully designed studies are needed to better estimate the extent of alterations in neurometabolites.